James K. Hennan

Tiplaxtinin, a Novel, Orally Efficacious Inhibitor of Plasminogen Activator Inhibitor-1:  Design, Synthesis, and Preclinical Characterization

Hassan Elokdah, Magid Abou‐Gharbia, James K. Hennan et al. · Journal of Medicinal Chemistry · 2004 · 166 citations · Full text

Pharmaceutical Science, Antiparasitic Agent, Cardiovascular Pharmacology +20

Effects of Selective Cyclooxygenase-2 Inhibition on Vascular Responses and Thrombosis in Canine Coronary Arteries

James K. Hennan, Jinbao Huang, Terrance D. Barrett et al. · Circulation · 2001 · 162 citations

Identification of ischemia-regulated phosphorylation sites in connexin43: A possible target for the antiarrhythmic peptide analogue rotigaptide (ZP123)

Lene Nygaard Axelsen, Martin Stahlhut, Shabaz Mohammed et al. · Journal of Molecular and Cellular Cardiology · 2006 · 133 citations

Signal Transduction, Biochemistry, G Protein-coupled Receptor +6

Model-Dependent Effects of the Gap Junction Conduction–Enhancing Antiarrhythmic Peptide Rotigaptide (ZP123) on Experimental Atrial Fibrillation in Dogs

Akiko Shiroshita-Takeshita, Masao Sakabe, Ketil Haugan et al. · Circulation · 2007 · 132 citations · Full text

C-Reactive-Protein-Associated Increase in Myocardial Infarct Size After Ischemia/Reperfusion

Terrance D. Barrett, James K. Hennan, Rory M. Marks et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 92 citations